Literature DB >> 19189932

Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal.

Jahannaz Dastgir1, Francis J DiMario.   

Abstract

Tumefactive demyelinating lesions are a known but uncommon complication of multiple sclerosis, a disease rarely reported in children. This is the case of a 16-year-old African American patient with multiple sclerosis, who developed 2 tumefactive demyelinating lesions. Review of the literature and our own experience helped formulate an algorithm for therapeutic options during an acute attack.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189932     DOI: 10.1177/0883073808324769

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

1.  Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.

Authors:  A Siri; Clarisse Carra-Dalliere; X Ayrignac; J Pelletier; B Audoin; S Pittion-Vouyovitch; M Debouverie; C Lionnet; F Viala; D Sablot; D Brassat; J-C Ouallet; A Ruet; B Brochet; L Taillandier; L Bauchet; N Derache; G Defer; P Cabre; J de Seze; C Lebrun Frenay; M Cohen; P Labauge
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

2.  Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update.

Authors:  Alberto Spalice; Pasquale Parisi; Laura Papetti; Francesco Nicita; Fabiana Ursitti; Francesca Del Balzo; Enrico Properzi; Alberto Verrotti; Martino Ruggieri; Paola Iannetti
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

Review 3.  Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.

Authors:  Simon Faissner; Robert Hoepner; Carsten Lukas; Andrew Chan; Ralf Gold; Gisa Ellrichmann
Journal:  Ther Adv Neurol Disord       Date:  2015-09       Impact factor: 6.570

Review 4.  Management of multiple sclerosis in adolescents - current treatment options and related adherence issues.

Authors:  Jean K Mah; Jennifer E Thannhauser
Journal:  Adolesc Health Med Ther       Date:  2010-06-17

5.  Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments.

Authors:  Staley A Brod; J William Lindsey; Flavia Nelson
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-06-18

6.  Commentary: Acute Hemorrhagic Leukoencephalitis (Weston-Hurst Syndrome) in a Patient with Relapse-Remitting Multiple Sclerosis.

Authors:  Tatiana Koudriavtseva
Journal:  Front Immunol       Date:  2016-05-25       Impact factor: 7.561

7.  Transtentorial herniation from tumefactive multiple sclerosis mimicking primary brain tumor.

Authors:  Kunal Vakharia; Haris Kamal; Gursant S Atwal; James L Budny
Journal:  Surg Neurol Int       Date:  2018-10-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.